Caris Life Sciences Publishes Study Showing its Multi-Layer AI-Based Tissue of Origin Predictions are Best-in-Class and Identify when Patients have been Misdiagnosed

This latest advancement marks a shift from traditional machine learning to a deep learning-based approach, enabling more precise prediction of tumor tissue of origin and the identification of potential misdiagnoses during routine molecular profiling, ultimately supporting more informed treatment decisions and potentially improving patient outcomes. The enhanced Caris GPSai was trained on WES/WTS data from over 200,000 Caris-profiled cases and classifies tumors into 90 categories. The tool demonstrated 95.0% ...